| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.162 | 3.496 | 10.094 | 8.711 | 7.282 | 4.081 |
| Total Income - EUR | - | - | - | - | 3.162 | 3.496 | 10.094 | 8.711 | 7.282 | 4.081 |
| Total Expenses - EUR | - | - | - | - | 2.350 | 2.427 | 1.294 | 2.748 | 3.697 | 1.382 |
| Gross Profit/Loss - EUR | - | - | - | - | 812 | 1.069 | 8.800 | 5.964 | 3.585 | 2.699 |
| Net Profit/Loss - EUR | - | - | - | - | 718 | 995 | 8.524 | 5.715 | 2.963 | 2.282 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gmajkatherapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 772 | 639 | 507 |
| Current Assets | - | - | - | - | 1.106 | 3.857 | 10.296 | 8.941 | 12.092 | 14.482 |
| Inventories | - | - | - | - | 0 | 573 | 560 | 1.960 | 1.955 | 1.944 |
| Receivables | - | - | - | - | 942 | 2.757 | 392 | 189 | 0 | 0 |
| Cash | - | - | - | - | 164 | 527 | 9.344 | 6.791 | 10.137 | 12.538 |
| Shareholders Funds | - | - | - | - | 760 | 1.740 | 10.225 | 9.663 | 12.597 | 10.656 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 346 | 2.117 | 71 | 49 | 135 | 4.332 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8891 - 8891" | |||||||||
| CAEN Financial Year |
8891
|
|||||||||
Comments - Gmajkatherapy S.r.l.